Clinical Trials Browser

Phase 2 × Human Papillomavirus Recombinant Vaccine nonavalent × 30 days × Clear all

NCT06658405 2026-03-18

HPV2

Phase 2 Recruiting

Neoplasms

NCT03036930 2026-03-11

Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients

Phase 2 Active not recruiting

51 enrolled 10 charts

Papillomavirus Infections